◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Krsnaa Diagnostics Limited (KRSNAA) Financial History

Name: Krsnaa Diagnostics Limited (KRSNAA) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Diagnostics & Research · DATA UPDATED 2026-09-20

Krsnaa Diagnostics Limited (KRSNAA) operates in the Diagnostics & Research industry and is headquartered in Pune, India with about 3,296 employees. Its market capitalization is roughly ₹18 billion. In the fiscal year ended 2026-03-31, KRSNAA reported ₹7.7B in revenue and ₹1.0B in net income.

Krsnaa Diagnostics Limited provides diagnostic services in India. It offers mammography, stress tests, dual-energy X-ray absorptiometry scans, bone mineral density tests, computed tomography scans, and magnetic resonance imaging services, as well as tele-radiology and tele-pathology services.

Interactive charts & full statements →

KRSNAA Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹7.7B	₹7.2B	₹6.2B	₹4.9B
Gross Profit	₹5.3B	₹4.9B	₹4.1B	₹3.3B
Operating Income (EBIT)	₹1.2B	₹1.0B	₹698M	₹692M
Net Income	₹1.0B	₹776M	₹568M	₹621M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

KRSNAA Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total Revenue	₹2.4B	₹1.9B	₹1.8B	₹2.1B	₹1.9B
Gross Profit	₹1.4B	₹1.3B	₹1.3B	₹1.4B	₹1.3B
Operating Income (EBIT)	₹300M	₹323M	₹238M	₹356M	₹298M
Net Income	₹166M	₹417M	₹152M	₹239M	₹205M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

KRSNAA Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(₹89M)	(₹81M)	(₹86M)	(₹78M)	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

KRSNAA Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹18.2B	₹12.8B	₹11.7B	₹9.1B	—
Total Liabilities	₹8.4B	₹4.0B	₹3.6B	₹1.7B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive KRSNAA viewer.

Other Companies in Diagnostics & Research

LONN · Lonza Group AG — CHF 38 billion
4671 · FALCO HOLDINGS Co., Ltd. — JPY 29 billion
VIMTALABS · Vimta Labs Limited — ₹27 billion
6127 · Joinn Laboratories(China)Co.,Ltd. — HK$19 billion
SURAKSHA · Suraksha Diagnostic Limited — ₹17 billion
ERF · Eurofins Scientific SE — €13 billion
BIM · bioMérieux S.A. — €8 billion
3386 · Cosmo Bio Company,Limited — JPY 7 billion

← KRRO All “K” companies KRSP →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.